The core technology and capability of the company is to scientifically and effectively develop innovative mechanism drugs with clinical differentiation and meeting clinical needs, supported by a comprehensive strategy of new drug molecular discovery, early evaluation, and clinical development through AI assisted design and chemical genomics technology platform.
